Hyloris reports full year results for 2022 & provides business outlook
Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing deals Potential…
Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing deals Potential…
LAWRENCEVILLE, N.J., March 15, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug…
PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON ITS MICROTUBULE DESTABILIZER AGENTS (MDA)…
Beirut, Lebanon–(Newsfile Corp. – March 15, 2023) – SCOPSIS, a digital transformation company, and OpSec…
C-suite executives from leading U.S. health systems report widespread investments in artificial intelligence (AI) to…
STAMFORD, Conn.–(BUSINESS WIRE)–#GartnerSales–Gartner, Inc. (NYSE: IT): What: Gartner CSO & Sales Leader Conference 2023 When:…
Ten recipients recognized for extraordinary contributions to MIPI specifications for mobile, IoT, security, automotive and…
The exclusive Channel Chiefs list recognizes the commitment of the selected executives and their companies…
Four-day conference provides in-person and virtual attendance options to inspire, educate and connect BIRMINGHAM, Mich.–(BUSINESS…
CCC’s Robust Software Solutions Fuel Scientific Research and Simplify Copyright DANVERS, Mass.–(BUSINESS WIRE)–#AI—CCC, a leader…
Prakash will oversee strategy and execution of public sector partnerships to ensure equitable and accessible…
Figure 1. Co-crystal 3D structure of the drug bound to the target enzyme, dCK, at…
Martinsried/Munich, March 15, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early-stage immuno-oncology platform…
HOUSTON, March 15, 2023 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
Discovery of novel immune checkpoints in the tumor microenvironment with iOTarg™ screening platform Predictive biomarker…
“Precise” delivers the same SUPERB™ technology in a compact applicator head for more convenient and…
Company Awaits Regulatory Clearance to Conduct Confirmatory Phase 2b Trial for Lead Product Candidate AD04™…
IRVINE, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”)…
VYVGART is the first neonatal Fc receptor (FcRn) blocker approved in the UK for the…
Accreditation will validate developers’ and engineers’ advanced knowledge of the LoRaWAN Standard LoRaWAN Accredited Professional…